Apparatus and method for heating biological targets

• US 9,956,028 B2
• Filed: 05/09/2011
• Issued: 05/01/2018
• Est. Priority Date: 05/09/2011
• Status: Active Grant

• Current Assignee: Innovolink, LLC
• Original Assignee: Innovolink, LLC
• Inventors: Marc, Michel
• Primary Examiner(s): Stoklosa, Joseph
• Assistant Examiner(s): AVIGAN, ADAM JOSEPH
• Application Number:
  US13/103,715
• Publication Number:
  US 20120289955A1
• Time in Patent Office: 2,549 Days
• Field of Search: 607 96-102
• CPC Class Codes: A61B 18/1206 Generators therefor
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 2018/1467 using more than two electrodes on a single probe
• CPC Class Codes: A61B 2018/147 Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue
• CPC Class Codes: A61B 2018/1472 for use with liquid electrolyte, e.g. virtual electrodes
• CPC Class Codes: A61K 2800/47 Magnetic materials; Paramagnetic compounds
• CPC Class Codes: A61K 2800/651 The particulate/core comprising inorganic material
• CPC Class Codes: A61K 2800/81 Preparation or application process involves irradiation
• CPC Class Codes: A61K 8/0241 Containing particulates characterized by their shape and/or structure see also A61K8/04, A61K8/11, and A61K8/14, further aspects are classified in A61K2800/40 and subcodes
• CPC Class Codes: A61K 8/19 containing inorganic ingredients
• CPC Class Codes: A61N 1/406 using implantable thermoseeds or injected particles for localized hyperthermia preparations of seeds and particles A61K41/0052
• CPC Class Codes: A61Q 19/06 for countering cellulitis

Abstract

An apparatus and method for selectively heating a biological target within a treatment region of a subject is disclosed. The method includes administering to the subject a dielectric heating modulator that becomes associated with the biological target. The method also includes positioning the treatment region between first and second electrodes connected to a generator, and activating the generator to apply an alternating electric field between the first and second electrodes and across the treatment region to thereby heat the treatment region. The dielectric heating modulator causes the biological target to heat at a faster rate than non-targets within the treatment region, which preferably results in the killing of the biological target.

Claims

1. A method for selectively heating a biological target of a subject via the application of an alternating electric field, comprising:

administering to said subject a dielectric heating modulator that becomes associated with said biological target;

positioning a treatment region of said subject between a first high voltage electrode and a second ground electrode, wherein said treatment region has a plurality of thicknesses extending between said first and second electrodes, the plurality of thicknesses comprising at least a first thickness and a second thickness, the first thickness being greater than the second thickness, wherein said treatment region contains a plurality of cells comprising said biological target and at least one non-target;

displacing any air located between said treatment region and said first and second electrodes with one or more flowable materials;

activating a generator connected to said first high voltage electrode and said second ground electrode, wherein said generator is operable to apply an alternating electric field between said first and second electrodes and across said treatment region to thereby heat said treatment region, wherein each flowable material is a mixture of at least two substances having relative concentrations calculated to optimize a dielectric constant and a dissipation factor of the mixture which causes said cells comprising said biological target to heat at a first rate and said cells comprising said non-target to heat at a second rate in both the first and second thicknesses and throughout the entire thicknesses of said treatment region between said first and second electrodes; and

wherein said application of said alternating electric field to said treatment region causes said cells comprising said biological target having said dielectric heating modulator associated therewith to increase in temperature at a faster rate than said cells comprising said non-target.

2. The method of claim 1 wherein said biological target is a neoplastic cell.

3. The method of claim 1 wherein said biological target is a tumor.

4. The method of claim 1 wherein said biological target is a malignant tumor.

5. The method of claim 1 wherein said biological target is an adipose cell.

6. The method of claim 1 wherein said biological target is selected from the group consisting of cardiac cancer cells, lung cancer cells, gastrointestinal cancer cells, genitourinary cancer cells, liver cancer cells, bone cancer cells, nervous system cancer cells, gynecological cancer cells, hematologic cancer cells, skin cancer cells, and adrenal gland cancer cells.

7. The method of claim 1 wherein said biological target is selected from the group consisting of bacterial cells, viruses, virally-infected cells, and parasites.

8. The method of claim 1 wherein said dielectric heating modulator is administered locally to said subject, and wherein said biological target is a tumor.

9. The method of claim 1 wherein said dielectric heating modulator is administered locally to said subject, and wherein said dielectric heating modulator is directly linked or indirectly associated with a targeting moiety that selectively binds to said biological target.

10. The method of claim 1 wherein said dielectric heating modulator is administered systemically to said subject, and wherein said dielectric heating modulator is directly linked or indirectly associated with a targeting moiety that selectively binds to said biological target.

11. The method of claim 1 wherein said dielectric heating modulator is an electrically conductive material.

12. The method of claim 1 wherein said dielectric heating modulator is a polar material.

13. The method of claim 1 wherein said dielectric heating modulator is an ionic material.

14. The method of claim 1 wherein said dielectric heating modulator is an electroconductive metal-containing nanoparticle.

15. The method of claim 1 wherein said dielectric heating modulator is selected from the group consisting of metal salts, metal oxides, metal colloids, and other metal complexes.

16. The method of claim 1 wherein said dielectric heating modulator is a nanoparticle having a particle size less than 50 nm and is comprised of a material selected from the group consisting of nickel, iron, copper, zinc, chromium, cobalt, aluminum, silver, gold, platinum, palladium, and alloys thereof.

17. The method of claim 1 wherein said dielectric heating modulator is a gold-containing nanoparticle or an iron-containing nanoparticle.

18. The method of claim 1 wherein said dielectric heating modulator is a gold salt selected from the group consisting of gold acetate, gold borate, gold bromide, gold butyrate, gold carbonate, gold chlorate, gold chloride, gold chromate, gold citrate, gold formate, gold glycinate, gold hydroxide, gold iodide, gold nitrate, gold oleate, gold oxalate, gold oxide, gold perchlorate, gold phosphate, gold salicylate, gold selenate, gold stearate, gold sulfide, and gold tartrate.

19. The method of claim 1 wherein said dielectric heating modulator is glucose or a glucose mimic.

20. The method of claim 1 wherein said dielectric heating modulator is directly linked or indirectly associated with a targeting moiety that selectively binds to said biological target.

21. The method of claim 1 wherein said activating step results in the killing of said biological target.

22. The method of claim 1 wherein said dielectric heating modulator is administered in a pharmaceutically acceptable carrier.

23. The method of claim 1 wherein said alternating electric field is generated at a frequency in the range of 1 MHz to 100 MHz.

24. The method of claim 1 wherein said alternating electric field is generated at a frequency of 27.12 MHz or 40.68 MHz.

25. The method of claim 1 wherein a substantially constant voltage is provided between said first and second electrodes such that a difference between a first voltage provided at a first point on said high voltage electrode compared to each of a plurality of additional voltages provided at each of a plurality of additional points on said high voltage electrode is less than ±

10%.

26. The method of claim 25 wherein said signal generated by said generator has a wavelength λ

, and wherein said treatment region is positioned between said first and second electrodes and adjacent a point on said first electrode that is located a distance of ¼

λ

or ¼

λ

plus a multiple of ½

λ

from said generator such that said substantially constant voltage is provided between said first and second electrodes.

27. The method of claim 1 wherein a substantially constant current passes between said first and second electrodes and through said treatment region such that a difference between a first current passing through a first portion of said treatment region compared to each other current passing through each other portion of said treatment region is less than ±

25%.

28. The method of claim 27 wherein the composition of each flowable material allows said substantially constant current to pass between said first and second electrodes and through said treatment region.

29. A method for selectively heating a biological target of a subject via the application of an alternating electric field, comprising:

systemically administering to said subject a dielectric heating modulator having a targeting moiety that selectively binds to said biological target;

positioning a treatment region of said subject between a first high voltage electrode and a second ground electrode, wherein said first electrode is parallel to said second electrode, wherein said treatment region has a plurality of thicknesses extending between said first and second electrodes, the plurality of thicknesses comprising at least a first thickness and a second thickness, the first thickness being greater than the second thickness, wherein said treatment region contains a plurality of cells comprising said biological target and at least one non-target;

displacing any air located between said treatment region and said first and second electrodes with one or more flowable materials;

activating a generator connected to said first high voltage electrode and said second ground electrode, wherein said generator is operable to apply said alternating electric field between said first and second electrodes and across said treatment region to thereby heat said treatment region, wherein each flowable material is made of a a mixture of at least two substances having relative concentrations calculated to optimize a dielectric constant and a dissipation factor of the mixture which causes said cells comprising said biological target to heat at a first rate and said cells comprising said non-target to heat at a second rate in both the first and second thicknesses and throughout the entire thicknesses of said treatment region between said first and second electrodes; and

wherein said dielectric heating modulator causes said cells comprising said biological target to heat at a faster rate than said cells comprising said non-target within said treatment region.

30. The method of claim 29 wherein said dielectric heating modulator is a nanoparticle having a particle size less than 50 nm and is comprised of a material selected from the group consisting of nickel, iron, copper, zinc, chromium, cobalt, aluminum, silver, gold, platinum, palladium, and alloys thereof.

31. The method of claim 29 wherein said dielectric heating modulator is an electrically conductive carbon black.

32. The method of claim 29 wherein said targeting moiety selectively binds to a tumor-associated antigen.

33. The method of claim 29 wherein said targeting moiety is an antibody or antibody fragment specific for said biological target.

34. The method of claim 29 wherein said biological target is a cancer cell and wherein said targeting moiety is selected from the group consisting of amino acids and peptides.

35. The method of claim 29 wherein said biological target is a cancer cell and wherein said targeting moiety is selected from the group consisting of glucose and glucose mimics.

36. The method of claim 29 wherein said biological target is a cancer cell and wherein said targeting moiety is a folate receptor targeting ligand.

37. The method of claim 29 wherein said targeting moiety is a signal peptide.

38. The method of claim 29 wherein said targeting moiety is an anaerobic bacteria having said dielectric heating modulator either internalized therein or attached thereto.

39. The method of claim 29 wherein said targeting moiety is a magnetic particle.

40. The method of claim 29 wherein said biological target is selected from the group consisting of cardiac cancer cells, lung cancer cells, gastrointestinal cancer cells, genitourinary cancer cells, liver cancer cells, bone cancer cells, nervous system cancer cells, gynecological cancer cells, hematologic cancer cells, skin cancer cells, and adrenal gland cancer cells.

41. A method for selectively heating cancer cells in a subject via the application of an alternating electric field, comprising:

administering to said subject a dielectric heating modulator, said dielectric heating modulator becoming associated with said cancer cells in said subject, and said cancer cells selected from the group consisting of cardiac cancer cells, lung cancer cells, gastrointestinal cancer cells, genitourinary cancer cells, liver cancer cells, bone cancer cells, nervous system cancer cells, gynecological cancer cells, hematologic cancer cells, skin cancer cells, and adrenal gland cancer cells;

positioning a treatment region of said subject between a first high voltage electrode and a second ground electrode, wherein said treatment region has a plurality of thicknesses extending between said first and second electrodes, the plurality of thicknesses comprising at least a first thickness and a second thickness, the first thickness being greater than the second thickness, wherein said treatment region contains said cancer cells and normal non-cancerous cells;

displacing any air located between said treatment region and said first and second electrodes with one or more flowable materials;

activating a generator connected to said first high voltage electrode and said second ground electrode, wherein said generator is operable to apply said alternating electric field between said first and second electrodes and across said treatment region to thereby heat said treatment region, wherein each flowable material is made of a mixture of at least two substances having relative concentrations calculated to optimize a dielectric constant and dissipation factor of the mixture which causes said cancer cells to heat at a first rate and said normal non-cancerous cells to heat at a second rate in both the first and second thicknesses and throughout the entire thicknesses of said treatment region between said first and second electrodes; and

wherein said dielectric heating modulator causes said cancer cells to heat at a faster rate than said normal non-cancerous cells within said treatment region.

42. The method of claim 41 wherein said dielectric heating modulator is a nanoparticle having a particle size less than 50 nm and is comprised of a material selected from the group consisting of nickel, iron, copper, zinc, chromium, cobalt, aluminum, silver, gold, platinum, palladium, and alloys thereof.

43. The method of claim 41, wherein said dielectric heating modulator is an electrically conductive carbon black.

44. The method of claim 41 wherein said dielectric heating modulator is directly linked or indirectly associated with a targeting moiety that selectively binds to said cancer cells.

45. The method of claim 41 wherein said targeting moiety selectively binds to a tumor-associated antigen.

46. The method of claim 44 wherein said targeting moiety is an antibody or antibody fragment specific to said tumor-associated antigen.

47. The method of claim 41 wherein said targeting moiety is selected from the group consisting of amino acids and peptides, glucose and glucose mimics, a folate receptor targeting ligand, and a signal peptide.

48. The method of claim 41 wherein said activating step results in the killing of said cancer cells and not said normal non-cancerous cells.

49. The method of claim 41 wherein said application of said alternating electric field to said treatment region causes said cancer cells having said dielectric heating modulator associated therewith to increase their temperature according to Δ

T₂ throughout the entire thickness of said treatment region while said normal non-cancerous cells increase their temperature according to Δ

T₁ throughout the entire thickness of said treatment region according to;

50. The method of claim 41 wherein said activating step results in said cancer cells being heated to about 45.5°

C. or more while said normal non-cancerous cells are heated to less than about 40°

C.

51. The method of claim 41 wherein said activating step results in said cancer cells being heated to about 45.5°

C. or more while said normal non-cancerous cells are heated to less than about 42°

C.

52. The method of claim 41 wherein said activating step occurs for about 5 minutes or less.

53. The method of claim 41 wherein said activating step occurs for about 20 seconds or less.

54. The method of claim 41 wherein said dielectric heating modulator comprises fructose.

55. The method of claim 41 wherein said activating step results in killing said cancer cells while said normal non-cancerous cells are heated to less than about 40°

C.

56. The method of claim 41 wherein said activating step results in killing said cancer cells while said normal non-cancerous cells are heated to less than about 42°

C.

57. The method of claim 41 wherein said activating step results in said normal non-cancerous cells being heated to less than about 40°

C.

58. The method of claim 41 wherein said activating step results in said normal non-cancerous cells being heated to less than about 42°

C.